Merck Suit Against Medicare: Constitutional Arguments Are Scathing, But Are They Persuasive?
Executive Summary
A suit designed to test the limits of the protections against judicial review that are embedded in the IRA could have more traction, some legal scholars suggest.
You may also be interested in...
Stealth Defense: Medicare, IRS Implementation May Weaken Pharma’s Arguments Against IRA
Flexibility included in guidance issued after many IRA lawsuits were filed put some of the arguments industry has made on shakier footing, legal experts explain.
Tracking Industry’s Lawsuits Against IRA’s Medicare Price Negotiations
Industry stakeholders have filed various lawsuits against the US government, attempting to slow down or block the implementation of a new Medicare drug price negotiation program. Pink Sheet's new chart tracks the developments.
Tracking Industry’s Lawsuits Against IRA’s Medicare Price Negotiations
Industry stakeholders have filed various lawsuits against the US government, attempting to slow down or block the implementation of a new Medicare drug price negotiation program. Scrip's new chart tracks the developments.